[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion

T de Baere, Y Arai, R Lencioni, JF Geschwind… - Cardiovascular and …, 2016 - Springer
Abstract Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called
conventional TACE, was developed in the early 1980s and widely adopted worldwide after …

Surgical and locoregional therapy of HCC: TACE

M Tsurusaki, T Murakami - Liver cancer, 2015 - karger.com
Transcatheter arterial chemoembolization (TACE) is performed worldwide for patients with
intermediate-stage hepatocellular carcinoma (HCC). TACE has produced survival …

[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer …

Y Cho, JW Choi, H Kwon, KY Kim… - Journal of Liver …, 2023 - synapse.koreamed.org
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …

GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs

T de Baere, F Deschamps, L Tselikas… - European journal of …, 2015 - academic.oup.com
Neuroendocrine tumors from gastro-pancreatic origin (GEP-NET) can be responsible for
liver metastases. Such metastases can be the dominant part of the disease as well due to …

Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria

RC Gaba, RJ Lewandowski… - Journal of vascular …, 2016 - pubmed.ncbi.nlm.nih.gov
Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and
Reporting Criteria Transcatheter Therapy for Hepatic Malignancy: Standardization of …

The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis

L Pung, M Ahmad, K Mueller, J Rosenberg… - Journal of Vascular and …, 2017 - Elsevier
Purpose To review available evidence for use of cone-beam CT during transcatheter arterial
chemoembolization in hepatocellular carcinoma (HCC) for detection of tumor and feeding …

Initiative on superselective conventional transarterial chemoembolization results (INSPIRE)

T de Baere, M Ronot, JW Chung, R Golfieri… - Cardiovascular and …, 2022 - Springer
Several publications show that superselective conventional TransArterial
ChemoEmbolization (cTACE), meaning cTACE performed selectively with a microcatheter …